All In Biotech

Drug Trial Radar · NCT01105767

Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees

Evaluating Strategies to Prevent Methicillin-resistant Staphylococcus Aureus Skin and Soft Tissue Infections in Military Trainees

Last checked: Nov 19, 2026Latest source record: Feb 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 30,209 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

30,209

Actual

Start

May 2010

Primary completion

Jan 2012

Study completion Jan 2012

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Centers for Disease Control and Prevention
First posted
Apr 16, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Prevention
Who can join
Male only, from 18 years, up to 42 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This cluster-randomized prospective study will evaluate the effect of hygiene-based intervention strategies on the incidence of overall SSTI and MRSA-associated SSTI among military trainees. The proposed interventions used singly or in combination include standardized training and education, and weekly chlorhexidine showers.

Conditions

  • Staphylococcus Aureus
  • MRSA Skin Infections
  • Staphylococcal Skin Infections

Interventions

  • Chlorhexidine gluconateDrug

    Self applied chlorhexidine body wash (4% chlorhexidine gluconate, Hibiclens®, Mӧlnlycke Heath Care, Norcross, Georgia) once a week to wash/cover the body (except the face and genitalia).

  • Supplemental training, education and hygieneOther

    Supplemental SSTI education for trainees and drill sergeants included pocket cards and posters. Drill sergeants received briefings on SSTI and skin inspection/minor wound care. Trainees were instructed to take an additional 10-minute shower with soap and a wash cloth every week. They were also issued a first aid kit.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Skin and Soft Tissue Infection (SSTI)Time frame: At the end of the 20 month study
  2. Incidence of Methicillin-resistant Staphylococcus Aureus (MRSA)-Associated SSTITime frame: At the end of the 20 month study

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Usa Meddac Mach

    Columbus, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.